4.7 Article

A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 5, Pages 1106-1116

Publisher

WILEY
DOI: 10.1002/ijc.30139

Keywords

squamous cell carcinoma; tumour heterogeneity; cell culture and xenograft model

Categories

Funding

  1. FPI
  2. Ramon y Cajal [MINECO RYC2010-07337]
  3. Spanish Ministry of Economy y Competivity (MINECO) [SAF2012-39749]
  4. Deutsche Jose Carreras Leukaemie Stiftung [DJCLS R 14/16]
  5. AFM Telethon [AFM 18738]
  6. Fundacio Internacional Josep Carreras, Foundation Obra Social la caixa
  7. Asociacion Espanola Contra el Cancer (AECC - Junta de Barcelona)

Ask authors/readers for more resources

Squamous cell carcinomas have a range of histopathological manifestations. The parameters that determine this clinically observed heterogeneity are not fully understood. Here, we report the generation of a cell culture model that reflects part of this heterogeneity. We have used the catalytic subunit of human telomerase hTERT and large T to immortalize primary UV-unexposed keratinocytes. Then, mutant HRAS G12V has been introduced to transform these immortal keratinocytes. When injected into immunosuppressed mice, transformed cells grew as xenografts with distinct histopathological characteristics. We observed three major tissue architectures: solid, sarcomatoid and cystic growth types, which were primarily composed of pleomorphic and basaloid cells but in some cases displayed focal apocrine differentiation. We demonstrate that the cells generated represent different stages of skin cancerogenesis and as such can be used to identify novel tumor-promoting alterations such as the overexpression of the PADI2 oncogene in solid-type SCC. Importantly, the cultured cells maintain the characteristics from the xenograft they were derived from while being amenable to manipulation and analysis. The availability of cell lines representing different clinical manifestations opens a new tool to study the stochastic and deterministic factors that cause case-to-case heterogeneity despite departing from the same set of oncogenes and the same genetic background.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available